1,355
Views
12
CrossRef citations to date
0
Altmetric
Reports

NEDD4 promotes cell growth and motility in hepatocellular carcinoma

, , , , , , , , , & show all
Pages 728-738 | Received 01 Nov 2017, Accepted 01 Feb 2018, Published online: 10 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Meng Yue, Zhennan Yun, Shiquan Li, Guoqiang Yan & Zhenhua Kang. (2021) NEDD4 triggers FOXA1 ubiquitination and promotes colon cancer progression under microRNA-340-5p suppression and ATF1 upregulation. RNA Biology 18:11, pages 1981-1995.
Read now

Articles from other publishers (11)

Wei Zhao, Jing Zhao, Kun Li, Yanjiao Hu, Dongxia Yang, Bin Tan & Jian Shi. (2023) Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma. Laboratory Investigation 103:9, pages 100193.
Crossref
Xianyan Tian, Yifei Chen, Ziluo Peng, Qiong Lin & Aiqin Sun. (2023) NEDD4 E3 ubiquitin ligases: Promising biomarkers and therapeutic targets for cancer. Biochemical Pharmacology 214, pages 115641.
Crossref
Maoyu Wang, Zhensheng Zhang, Zhizhou Li, Yasheng Zhu & Chuanliang Xu. (2023) E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies. Frontiers in Immunology 14.
Crossref
Sujitha Jayaprakash, Mangala Hegde, Bandari BharathwajChetty, Sosmitha Girisa, Mohammed S. Alqahtani, Mohamed Abbas, Gautam Sethi & Ajaikumar B. Kunnumakkara. (2022) Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. International Journal of Molecular Sciences 23:20, pages 12380.
Crossref
Geofrey Mahiki Mranda, Zhi-Ping Xiang, Jun-Jian Liu, Tian Wei & Yinlu Ding. (2022) Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway. Frontiers in Oncology 12.
Crossref
Minghuan Mao, Liang Yang, Jingyao Hu, Bing Liu, Xiling Zhang, Yili Liu, Ping Wang & Hangyu Li. (2022) Oncogenic E3 ubiquitin ligase NEDD4 binds to KLF8 and regulates the microRNA-132/NRF2 axis in bladder cancer. Experimental & Molecular Medicine 54:1, pages 47-60.
Crossref
Tao Wan, Zhao Lei, Biao Tu, Tianyin Wang, Jiale Wang & Feizhou Huang. (2021) NEDD4 Induces K48-Linked Degradative Ubiquitination of Hepatitis B Virus X Protein and Inhibits HBV-Associated HCC Progression. Frontiers in Oncology 11.
Crossref
Md. Ezazul Haque, Md. Jakaria, Mahbuba Akther, Duk-Yeon Cho, In-Su Kim & Dong-Kug Choi. (2021) The GCN5: its biological functions and therapeutic potentials. Clinical Science 135:1, pages 231-257.
Crossref
Qifan Zhang, Yunbin Zhang, Shibo Sun, Kai Wang, Jianping Qian, Zhonglin Cui, Tao Tao & Jie Zhou. (2021) ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway. Cell Death & Disease 12:1.
Crossref
Zhi-wei Wang, Xiaoli Hu, Miaomiao Ye, Min Lin, Man Chu & Xian Shen. (2020) NEDD4 E3 ligase: Functions and mechanism in human cancer. Seminars in Cancer Biology 67, pages 92-101.
Crossref
Lingfeng Wan, Tao Liu, Zhipeng Hong, You Pan, Steven T. Sizemore, Junran Zhang & Zhefu Ma. (2019) NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis. Breast Cancer Research 21:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.